$USM
UNITED STATES CELLULAR CORP

2020 Q1 Form 10-Q Financial Statement

#000082113020000046 Filed on April 30, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $963.0M $966.0M
YoY Change -0.31% 2.55%
Cost Of Revenue $397.0M $409.0M
YoY Change -2.93% 2.76%
Gross Profit $566.0M $557.0M
YoY Change 1.62% 2.39%
Gross Profit Margin 58.77% 57.66%
Selling, General & Admin $335.0M $326.0M
YoY Change 2.76% 0.0%
% of Gross Profit 59.19% 58.53%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $177.0M $169.0M
YoY Change 4.73% 6.29%
% of Gross Profit 31.27% 30.34%
Operating Expenses $913.0M $902.0M
YoY Change 1.22% 2.85%
Operating Profit $50.00M $64.00M
YoY Change -21.88% -1.54%
Interest Expense $24.00M $29.00M
YoY Change -17.24% 0.0%
% of Operating Profit 48.0% 45.31%
Other Income/Expense, Net $26.00M $21.00M
YoY Change 23.81% 75.0%
Pretax Income $76.00M $85.00M
YoY Change -10.59% 10.39%
Income Tax $4.000M $27.00M
% Of Pretax Income 5.26% 31.76%
Net Earnings $71.00M $54.00M
YoY Change 31.48% 20.0%
Net Earnings / Revenue 7.37% 5.59%
Basic Earnings Per Share $0.82 $0.63
Diluted Earnings Per Share $0.81 $0.62
COMMON SHARES
Basic Shares Outstanding 86.00M shares 86.00M shares
Diluted Shares Outstanding 88.00M shares 88.00M shares

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $258.0M $665.0M
YoY Change -61.2% 30.65%
Cash & Equivalents $258.0M $648.0M
Short-Term Investments $17.00M
Other Short-Term Assets $22.00M $29.00M
YoY Change -24.14% -70.41%
Inventory $212.0M $157.0M
Prepaid Expenses $58.00M $50.00M
Receivables $865.0M $882.0M
Other Receivables $136.0M $38.00M
Total Short-Term Assets $1.576B $1.839B
YoY Change -14.3% 15.59%
LONG-TERM ASSETS
Property, Plant & Equipment $2.268B $2.137B
YoY Change 6.13% -4.3%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $461.0M $460.0M
YoY Change 0.22% 2.22%
Other Assets $534.0M $567.0M
YoY Change -5.82% 4.42%
Total Long-Term Assets $6.675B $6.390B
YoY Change 4.46% 17.1%
TOTAL ASSETS
Total Short-Term Assets $1.576B $1.839B
Total Long-Term Assets $6.675B $6.390B
Total Assets $8.251B $8.229B
YoY Change 0.27% 16.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $328.0M $364.0M
YoY Change -9.89% 32.36%
Accrued Expenses $183.0M $175.0M
YoY Change 4.57% 73.27%
Deferred Revenue $139.0M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $6.000M $19.00M
YoY Change -68.42% 5.56%
Total Short-Term Liabilities $722.0M $802.0M
YoY Change -9.98% 30.19%
LONG-TERM LIABILITIES
Long-Term Debt $1.503B $1.601B
YoY Change -6.12% -1.05%
Other Long-Term Liabilities $327.0M $292.0M
YoY Change 11.99% -18.66%
Total Long-Term Liabilities $327.0M $292.0M
YoY Change 11.99% -85.23%
TOTAL LIABILITIES
Total Short-Term Liabilities $722.0M $802.0M
Total Long-Term Liabilities $327.0M $292.0M
Total Liabilities $1.049B $1.094B
YoY Change -4.11% -65.17%
SHAREHOLDERS EQUITY
Retained Earnings $2.620B $2.497B
YoY Change 4.93%
Common Stock $88.00M $88.00M
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $92.00M $63.00M
YoY Change 46.03%
Treasury Stock Shares
Shareholders Equity $4.252B $4.121B
YoY Change
Total Liabilities & Shareholders Equity $8.251B $8.229B
YoY Change 0.27% 16.76%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income $71.00M $54.00M
YoY Change 31.48% 20.0%
Depreciation, Depletion And Amortization $177.0M $169.0M
YoY Change 4.73% 6.29%
Cash From Operating Activities $342.0M $287.0M
YoY Change 19.16% 52.66%
INVESTING ACTIVITIES
Capital Expenditures -$341.0M -$108.0M
YoY Change 215.74% 40.26%
Acquisitions
YoY Change
Other Investing Activities $0.00 $1.000M
YoY Change -100.0%
Cash From Investing Activities -$342.0M -$212.0M
YoY Change 61.32% 821.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $21.00M $0.00
YoY Change
Debt Paid & Issued, Net $2.000M $5.000M
YoY Change -60.0% 0.0%
Cash From Financing Activities -$24.00M -$6.000M
YoY Change 300.0% -14.29%
NET CHANGE
Cash From Operating Activities $342.0M $287.0M
Cash From Investing Activities -$342.0M -$212.0M
Cash From Financing Activities -$24.00M -$6.000M
Net Change In Cash -$24.00M $69.00M
YoY Change -134.78% -56.33%
FREE CASH FLOW
Cash From Operating Activities $342.0M $287.0M
Capital Expenditures -$341.0M -$108.0M
Free Cash Flow $683.0M $395.0M
YoY Change 72.91% 49.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
19000000 USD
CY2020Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P9M
CY2020Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000821130
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
70000000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
77000000 USD
CY2019Q4 us-gaap Allowance For Doubtful Other Receivables Current
AllowanceForDoubtfulOtherReceivablesCurrent
1000000 USD
CY2020Q1 us-gaap Allowance For Doubtful Other Receivables Current
AllowanceForDoubtfulOtherReceivablesCurrent
1000000 USD
CY2019Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
27000000 USD
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
190000000 shares
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
190000000 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
88000000 shares
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
88000000 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
86000000 shares
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
85000000 shares
CY2019Q1 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
20000000 USD
CY2020Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q1 dei Entity File Number
EntityFileNumber
001-09712
CY2019Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
44000000 USD
CY2019Q1 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
2000000 USD
CY2020Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
4000000 USD
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
913000000 USD
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
UNITED STATES CELLULAR CORPORATION
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
902000000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
50000000 USD
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
64000000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
45000000 USD
CY2020Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
62-1147325
CY2020Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
8410 West Bryn Mawr
CY2020Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Chicago
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2020Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60631
CY2020Q1 dei City Area Code
CityAreaCode
(773)
CY2020Q1 dei Local Phone Number
LocalPhoneNumber
399-8900
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q1 us-gaap Revenues
Revenues
963000000 USD
CY2019Q1 us-gaap Revenues
Revenues
966000000 USD
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
335000000 USD
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
326000000 USD
CY2020Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
177000000 USD
CY2019Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
169000000 USD
CY2020Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-4000000 USD
CY2019Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2000000 USD
CY2020Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
CY2019Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
2000000 USD
CY2020Q1 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
0 USD
CY2019Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
6000000 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
24000000 USD
CY2019Q1 us-gaap Interest Expense
InterestExpense
29000000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000000 USD
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
26000000 USD
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
21000000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
76000000 USD
CY2020Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
0 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
85000000 USD
CY2019Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2000000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000000 USD
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27000000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
72000000 USD
CY2019Q1 us-gaap Profit Loss
ProfitLoss
58000000 USD
CY2020Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
CY2019Q1 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
7000000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
-49000000 USD
CY2019Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
2000000 USD
CY2020Q1 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
0 USD
CY2019Q1 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
2000000 USD
CY2019Q1 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
11000000 USD
CY2020Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-4000000 USD
CY2020Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
9000000 USD
CY2019Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
9000000 USD
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 USD
CY2019Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4000000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
71000000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
54000000 USD
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86000000 shares
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86000000 shares
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.82
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
88000000 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
88000000 shares
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.81
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.62
CY2020Q1 us-gaap Profit Loss
ProfitLoss
72000000 USD
CY2019Q1 us-gaap Profit Loss
ProfitLoss
58000000 USD
CY2020Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
177000000 USD
CY2019Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
169000000 USD
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
33000000 USD
CY2019Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
24000000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7000000 USD
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
9000000 USD
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
52000000 USD
CY2019Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
17000000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
45000000 USD
CY2019Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
44000000 USD
CY2020Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
24000000 USD
CY2019Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
18000000 USD
CY2019Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
1000000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-55000000 USD
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-31000000 USD
CY2020Q1 us-gaap Increase Decrease In Finance Receivables
IncreaseDecreaseInFinanceReceivables
-23000000 USD
CY2019Q1 us-gaap Increase Decrease In Finance Receivables
IncreaseDecreaseInFinanceReceivables
10000000 USD
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
50000000 USD
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
15000000 USD
CY2020Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
315000000 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
57000000 USD
CY2019Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
107000000 USD
CY2020Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
26000000 USD
CY2019Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
52000000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
97000000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
342000000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
287000000 USD
CY2019Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
56000000 USD
CY2020Q1 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-10000000 USD
CY2019Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1000000 USD
CY2020Q1 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
0 USD
CY2019Q1 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
2000000 USD
CY2020Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1000000 USD
CY2019Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1000000 USD
CY2020Q1 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 USD
CY2019Q1 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
31000000 USD
CY2020Q1 usm Advance Paymentfor License Acquisition
AdvancePaymentforLicenseAcquisition
0 USD
CY2019Q1 usm Advance Paymentfor License Acquisition
AdvancePaymentforLicenseAcquisition
135000000 USD
CY2020Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
CY2019Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1000000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-342000000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-212000000 USD
CY2020Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2000000 USD
CY2019Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
5000000 USD
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
21000000 USD
CY2019Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2020Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
1000000 USD
CY2019Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
1000000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-24000000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6000000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-24000000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
69000000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
291000000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
583000000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
267000000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
652000000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
258000000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
285000000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
865000000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
919000000 USD
CY2020Q1 usm Receivables Net Current Roaming
ReceivablesNetCurrentRoaming
24000000 USD
CY2019Q4 usm Receivables Net Current Roaming
ReceivablesNetCurrentRoaming
27000000 USD
CY2020Q1 us-gaap Due From Affiliate Current
DueFromAffiliateCurrent
1000000 USD
CY2019Q4 us-gaap Due From Affiliate Current
DueFromAffiliateCurrent
1000000 USD
CY2020Q1 us-gaap Other Receivables
OtherReceivables
40000000 USD
CY2019Q4 us-gaap Other Receivables
OtherReceivables
63000000 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
212000000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
162000000 USD
CY2020Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
58000000 USD
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
50000000 USD
CY2020Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
96000000 USD
CY2019Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
46000000 USD
CY2020Q1 us-gaap Other Assets Current
OtherAssetsCurrent
22000000 USD
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
20000000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
1576000000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
1573000000 USD
CY2020Q1 us-gaap Indefinite Lived License Agreements
IndefiniteLivedLicenseAgreements
2502000000 USD
CY2019Q4 us-gaap Indefinite Lived License Agreements
IndefiniteLivedLicenseAgreements
2471000000 USD
CY2020Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
469000000 USD
CY2019Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
447000000 USD
CY2020Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8485000000 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8293000000 USD
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6217000000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6086000000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2268000000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2207000000 USD
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
902000000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
900000000 USD
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
534000000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
566000000 USD
CY2020Q1 us-gaap Assets
Assets
8251000000 USD
CY2019Q4 us-gaap Assets
Assets
8164000000 USD
CY2020Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
6000000 USD
CY2019Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
8000000 USD
CY2020Q1 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
7000000 USD
CY2019Q4 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
8000000 USD
CY2020Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
321000000 USD
CY2019Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
296000000 USD
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
139000000 USD
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
148000000 USD
CY2020Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
27000000 USD
CY2019Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
30000000 USD
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
47000000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
76000000 USD
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
109000000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
105000000 USD
CY2020Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
66000000 USD
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
79000000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
722000000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
750000000 USD
CY2020Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
559000000 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
507000000 USD
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
865000000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
865000000 USD
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
327000000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
319000000 USD
CY2020Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
1503000000 USD
CY2019Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
1502000000 USD
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q1 us-gaap Redeemable Noncontrolling Interest Equity Other Carrying Amount
RedeemableNoncontrollingInterestEquityOtherCarryingAmount
11000000 USD
CY2019Q4 us-gaap Redeemable Noncontrolling Interest Equity Other Carrying Amount
RedeemableNoncontrollingInterestEquityOtherCarryingAmount
11000000 USD
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
88000000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
88000000 USD
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1636000000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1629000000 USD
CY2020Q1 us-gaap Treasury Stock Value
TreasuryStockValue
92000000 USD
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
70000000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2620000000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2550000000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
4252000000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
4197000000 USD
CY2020Q1 us-gaap Minority Interest
MinorityInterest
12000000 USD
CY2019Q4 us-gaap Minority Interest
MinorityInterest
13000000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4264000000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4210000000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8251000000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8164000000 USD
CY2020Q1 us-gaap Variable Interest Entity Consolidated Assets Pledged
VariableInterestEntityConsolidatedAssetsPledged
933000000 USD
CY2019Q4 us-gaap Variable Interest Entity Consolidated Assets Pledged
VariableInterestEntityConsolidatedAssetsPledged
930000000 USD
CY2020Q1 us-gaap Variable Interest Entity Consolidated Liabilities No Recourse
VariableInterestEntityConsolidatedLiabilitiesNoRecourse
20000000 USD
CY2019Q4 us-gaap Variable Interest Entity Consolidated Liabilities No Recourse
VariableInterestEntityConsolidatedLiabilitiesNoRecourse
22000000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4210000000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
71000000 USD
CY2020Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
23000000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7000000 USD
CY2020Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1000000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4264000000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4067000000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
54000000 USD
CY2019Q1 usm Minority Interest In Net Income Loss Equity Minority Interests
MinorityInterestInNetIncomeLossEquityMinorityInterests
4000000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1000000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9000000 USD
CY2019Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1000000 USD
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4134000000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
258000000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
285000000 USD
CY2020Q1 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
9000000 USD
CY2019Q4 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
6000000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
267000000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
291000000 USD
CY2020Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
7000000 USD
CY2019Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
7000000 USD
CY2020Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
146000000 USD
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
154000000 USD
CY2020Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
99000000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
944000000 USD
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
950000000 USD
CY2020Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
19000000 USD
CY2019Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
16000000 USD
CY2020Q1 us-gaap Revenues
Revenues
963000000 USD
CY2019Q1 us-gaap Revenues
Revenues
966000000 USD
CY2020Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
180000000 USD
CY2020Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
100000000 USD
CY2020Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
164000000 USD
CY2020Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
444000000 USD
CY2020Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
127000000 USD
CY2019Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
133000000 USD
CY2020Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
27000000 USD
CY2020Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
964000000 USD
CY2019Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1008000000 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
90000000 USD
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
84000000 USD
CY2020Q1 us-gaap Notes Receivable Net
NotesReceivableNet
874000000 USD
CY2019Q4 us-gaap Notes Receivable Net
NotesReceivableNet
924000000 USD
CY2020Q1 us-gaap Notes Receivable Net
NotesReceivableNet
874000000 USD
CY2019Q4 us-gaap Notes Receivable Net
NotesReceivableNet
924000000 USD
CY2020Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
964000000 USD
CY2019Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1008000000 USD
CY2020Q1 us-gaap Financing Receivable Originated Three Years Before Latest Fiscal Year
FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear
16000000 USD
CY2020Q1 us-gaap Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
223000000 USD
CY2020Q1 us-gaap Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
569000000 USD
CY2020Q1 us-gaap Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
156000000 USD
CY2020Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
964000000 USD
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.050
CY2019Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.314
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
71000000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
54000000 USD
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86000000 shares
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86000000 shares
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2000000 shares
CY2019Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2000000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
88000000 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
88000000 shares
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.82
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.81
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.62
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1000000 shares
CY2019Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2471000000 USD
CY2020Q1 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
30000000 USD
CY2020Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
1000000 USD
CY2020Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2502000000 USD
CY2020Q1 us-gaap Equity Method Investments
EquityMethodInvestments
461000000 USD
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
440000000 USD
CY2020Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
8000000 USD
CY2019Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
7000000 USD
CY2020Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
469000000 USD
CY2019Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
447000000 USD
CY2020Q1 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
1657000000 USD
CY2019Q1 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
1689000000 USD
CY2020Q1 us-gaap Equity Method Investment Summarized Financial Information Cost Of Sales
EquityMethodInvestmentSummarizedFinancialInformationCostOfSales
1162000000 USD
CY2019Q1 us-gaap Equity Method Investment Summarized Financial Information Cost Of Sales
EquityMethodInvestmentSummarizedFinancialInformationCostOfSales
1215000000 USD
CY2020Q1 us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
495000000 USD
CY2019Q1 us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
474000000 USD
CY2020Q1 usm Equity Method Investment Summarized Financial Information Other Income Expense
EquityMethodInvestmentSummarizedFinancialInformationOtherIncomeExpense
3000000 USD
CY2019Q1 usm Equity Method Investment Summarized Financial Information Other Income Expense
EquityMethodInvestmentSummarizedFinancialInformationOtherIncomeExpense
-5000000 USD
CY2020Q1 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
498000000 USD
CY2019Q1 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
469000000 USD
CY2020Q1 us-gaap Variable Interest Entity Entity Maximum Loss Exposure Amount
VariableInterestEntityEntityMaximumLossExposureAmount
4000000 USD
CY2019Q4 us-gaap Variable Interest Entity Entity Maximum Loss Exposure Amount
VariableInterestEntityEntityMaximumLossExposureAmount
5000000 USD
CY2020Q1 us-gaap Variable Interest Entity Financial Or Other Support Amount
VariableInterestEntityFinancialOrOtherSupportAmount
69000000 USD
CY2019Q1 us-gaap Variable Interest Entity Financial Or Other Support Amount
VariableInterestEntityFinancialOrOtherSupportAmount
183000000 USD
CY2020Q2 us-gaap Line Of Credit
LineOfCredit
125000000 USD

Files In Submission

Name View Source Status
0000821130-20-000046-index-headers.html Edgar Link pending
0000821130-20-000046-index.html Edgar Link pending
0000821130-20-000046.txt Edgar Link pending
0000821130-20-000046-xbrl.zip Edgar Link pending
a10kusmoperating2020q1ca01.jpg Edgar Link pending
cacbe9711b2_image2a07.jpg Edgar Link pending
chart-23b2627f8a175e76a82.jpg Edgar Link pending
chart-60f02ef9c48150d8aad.jpg Edgar Link pending
chart-a364ef9d155650c9a94.jpg Edgar Link pending
chart-faf5b672cc645cd89d4.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
uscelllogoa07.jpg Edgar Link pending
usm-20200331.xsd Edgar Link pending
usm-20200331_cal.xml Edgar Link unprocessable
usm-20200331_def.xml Edgar Link unprocessable
usm-20200331_lab.xml Edgar Link unprocessable
usm-20200331_pre.xml Edgar Link unprocessable
usm331202010q.htm Edgar Link pending
usm331202010q_htm.xml Edgar Link completed
usm3312020ex311.htm Edgar Link pending
usm3312020ex312.htm Edgar Link pending
usm3312020ex321.htm Edgar Link pending
usm3312020ex322.htm Edgar Link pending